From Complaint Handling to Active Surveillance
May 5, 2026
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in MedTech Intelligence’s latest issue, where he discusses device safety monitoring. Read article
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in MedTech Intelligence’s latest issue, where he discusses device safety monitoring. Read article
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in MedTech Intelligence’s latest issue, where he discusses continuous safety surveillance for medical devices. Read
Chemistry Today asks Daniel O’Keeffe of Qinecsa Solutions if patient outcomes are getting lost in safety data complexity in a recent article. Daniel explores where AI
HaloPV is advanced pharmacovigilance technology that streamlines case management, signal detection and compliance to keep patient safety first worldwide.
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in chemistry Today’s latest issue, where he discusses why 2026 is the inflection point for
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, “Women Making an Impact,” published around the International Day of Women
Qinecsa VP, Product Management: Reportum, Daniel O’Keeffe, has been published in Drug Discovery Today (by Elsevier) and is available behind a paywall. In the piece,
Qinecsa Chief Operating Officer, John Cogan, has been featured in Pharma Times latest issue, where he predicts where is the industry setting its sights for
London, UK – March 09th, 2026 – Qinecsa, the global class leader in technology-powered pharmacovigilance solutions, has announced the release of HaloPV 6.2, the latest update to its